Suzhou Erye Pharmaceutical Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Suzhou Erye Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts (NCT06055777) | Suzhou Erye Pharmaceutical Co., Ltd. | 2023-09-07 |
Track Suzhou Erye Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.